Author Page for Justin W. Shearer

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Compliance and Regulatory Considerations for the Implementation of the Multi-Attribute-Method by Mass Spectrometry in a Quality Control Laboratory

Number of pages: 30 Posted: 26 Jul 2023

Annick Gervais, Eef H. C. Dirksen, Thomas Pohl, Karoline Bechtold-Peters, Will Burkitt, Valerio D’Alessio, Simone Greven, Andrew Lennard, Xue Li, Christopher Lössner, Ben Niu, Dietmar Reusch, Tomás O’Riordan, Justin W. Shearer, David Spencer, Wei Xu and Linda Yi

UCB, Byondis - Analytical Development and Quality Control, Novartis Institutes for Biomedical Research, Cambridge - Novartis Pharma AG, Novartis Pharma AG, UCB - Biological Characterisation Product Development Sciences, Merck Serono S.p.A. - Analytical Development & Innovation NBE, Bayer AG, Amgen Ltd, Bristol Myers Squibb, SCM, Boehringer Ingelheim Pharma GmbH & Co. KG, Bristol Myers Squibb, Roche Diagnostics GmbH Penzberg, Eli Lilly Kinsale Limited, GSK, Ipsen Biopharm Limited - BioPharmaceutical Development, AstraZeneca Pharmaceuticals - BioPharmaceuticals R&D and Biogen

Downloads 64 (924,743)

Citation 2

Justin W. Shearer

GSK

1

64

2

Scholarly Papers (1)

Compliance and Regulatory Considerations for the Implementation of the Multi-Attribute-Method by Mass Spectrometry in a Quality Control Laboratory

Abstract: